- ICH GCP
- US Clinical Trials Registry
- Researchers
- Netherlands
- Pancreatic Neoplasms
Medical specialists from Netherlands tagged as investigators in clinical trials studying Pancreatic Neoplasms
Total 19 results
-
Alexander Vahrmeijer, MD, PhDSeen in:
- Leiden, Leiden University Medical Center
Trials:- NCT05518071 (Principal Investigator)
- NCT05984810 (Principal Investigator)
- NCT06155734 (Principal Investigator)
- NCT06395337 (Principal Investigator)
-
Bart Geboers, MDSeen in:
- North-Holland, Amsterdam, Amsterdam University Medical Centre (location VUmc)
Trials:- NCT04612530 (Sub-Investigator)
Conditions: -
Carla ML van Herpen, MD, PhDSeen in:
- Gelderland, Nijmegen, Radboudumc
- Gelderland, Nijmegen, UMC St. Radboud Nijmegen
Trials:- NCT04291300 (Principal Investigator)
- NCT04214353 (Principal Investigator)
- NCT05513365 (Principal Investigator)
- NCT02450656 (Principal Investigator)
-
Casper van Eijck, Prof, MD, PhDSeen in:
- Zuid-Holland, Rotterdam, Erasmus MC
Trials:- NCT05650918 (Sub-Investigator)
- NCT05927142 (Sub-Investigator)
Conditions: -
Eelke Gort, MDSeen in:
- Utrecht, UMC Utrecht
Trials:- NCT03786081 (Principal Investigator)
- NCT02912949 (Principal Investigator)
-
F Opdam, MD, PhDSeen in:
- Amsterdam, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Trials:- NCT05518799 (Principal Investigator)
- NCT02450656 (Principal Investigator)
-
Florentine EF Timmer, MScSeen in:
- North-Holland, Amsterdam, Amsterdam University Medical Centre (location VUmc)
Trials:- NCT04612530 (Sub-Investigator)
Conditions: -
Frank Nijsen, PhDSeen in:
- Gelderland, Nijmegen, Radboud University Medical Centre
Trials:- NCT05191498 (Principal Investigator)
- NCT05880472 (Principal Investigator)
Conditions: -
Frans Opdam, MDSeen in:
- Amsterdam, NKI
- Amsterdam, Netherlands Cancer Institute
Trials:- NCT02912949 (Principal Investigator)
- NCT04868877 (Principal Investigator)
-
H Verheul, Prof, MD, PhDSeen in:
- Zuid-Holland, Rotterdam, Erasmus MC
Trials:- NCT05927142 (Sub-Investigator)
Conditions: -
Hans Hofland, DrSeen in:
- GD, Rotterdam, Erasmus University Medical Center
Trials:- NCT04524442 (Principal Investigator)
Conditions: -
Helena M Verkooijen, Prof, DrSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT04075305 (Principal Investigator)
Conditions:- Neoplasms;
- Quality of Life;
- Breast Cancer;
- Head and Neck Cancer;
- Head and Neck Neoplasms;
- Gynecologic Cancer;
- Liver Neoplasms;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Esophageal Cancer;
- Lung Cancer;
- Rectal Cancer;
- Rectal Neoplasms;
- Prostate Cancer;
- Brain Cancer;
- Brain Tumor;
- Bladder Cancer;
- Liver Metastases;
- Tumor;
- Radiation Toxicity;
- Liver Cancer;
- Oncology;
- Prostate Neoplasm;
- Head and Neck Tumor;
- Oligometastases;
- Esophageal Neoplasm;
- Esophagus Cancer;
- Lung Neoplasm;
- Breast Tumor;
- Rectal Tumor;
- Pancreatic Tumor;
- Esophageal Tumor;
- Gynecologic Tumor;
- Prostate Tumor;
- Lung Tumor;
- Esophagus Tumor;
- Esophagus Neoplasm;
- Bladder Neoplasm
-
JHW de Wilt, MD, PhDSeen in:
- Nijmegen, Radboudumc
Trials:- NCT06395337 (Principal Investigator)
Conditions: -
M. van Vulpen, Prof MD PhDSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT01898741 (Principal Investigator)
Conditions: -
Marc G Besselink, MD, PhD, MScSeen in:
- Noord-Holland, Amsterdam, Amsterdam UMC, Locatie AMC
Trials:- NCT05524090 (Principal Investigator)
- NCT05906615 (Principal Investigator)
-
Marjolein Homs, MD, PhDSeen in:
- Zuid-Holland, Rotterdam, Erasmus MC
Trials:- NCT05927142 (Principal Investigator)
Conditions: -
Marnix Lam, MDSeen in:
- Utrecht, UMC Utrecht
Trials:- NCT05477576 (Principal Investigator)
-
Martijn R Meijerink, MD, PhDSeen in:
- North-Holland, Amsterdam, Amsterdam University Medical Centre (location VUmc)
Trials:- NCT04612530 (Principal Investigator)
Conditions: -
Tessa LeerSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT04075305 (Sub-Investigator)
Conditions:- Neoplasms;
- Quality of Life;
- Breast Cancer;
- Head and Neck Cancer;
- Head and Neck Neoplasms;
- Gynecologic Cancer;
- Liver Neoplasms;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Esophageal Cancer;
- Lung Cancer;
- Rectal Cancer;
- Rectal Neoplasms;
- Prostate Cancer;
- Brain Cancer;
- Brain Tumor;
- Bladder Cancer;
- Liver Metastases;
- Tumor;
- Radiation Toxicity;
- Liver Cancer;
- Oncology;
- Prostate Neoplasm;
- Head and Neck Tumor;
- Oligometastases;
- Esophageal Neoplasm;
- Esophagus Cancer;
- Lung Neoplasm;
- Breast Tumor;
- Rectal Tumor;
- Pancreatic Tumor;
- Esophageal Tumor;
- Gynecologic Tumor;
- Prostate Tumor;
- Lung Tumor;
- Esophagus Tumor;
- Esophagus Neoplasm;
- Bladder Neoplasm
Clinical Trials on Pancreatic Neoplasms
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
Laser Tissue Welding, Inc.National Cancer Institute (NCI); CHI St. Luke's Health, TexasCompletedPancreatic Neoplasms | Pancreatic Adenocarcinoma | Pancreatic Cyst | Pancreatic Neuroendocrine Tumor | Pancreatic Polypeptide Tumor | Pancreatic Pseudocyst | Pancreatic Glucagonoma | Pancreas Injury | Pancreatic Cystadenoma | Pancreatic Tumor, Benign | Pancreas; Insulinoma | Pancreatic Teratoma | Pancreatic Vipoma and other conditionsUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Pancreatic NeoplasmChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer